Amwell® Announces Results for Second Quarter 2025
Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its financial results for the second quarter ended June 30, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its financial results for the second quarter ended June 30, 2025. The company will discuss these results during a conference call scheduled for 5 p.m. ET on August 5, 2025.
The earnings report is available on the company's investor relations website, and a live audio webcast of the conference call will be accessible online. A replay of the webcast will remain available for approximately 90 days on the investor relations website.
Details
News Market Reaction – AMWL
On Aug 6, the first trading day after this news, AMWL closed 7.31% below the previous close.
Data tracked by StockTitan Argus for the Aug 6 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company’s second quarter earnings report may be viewed at investors.amwell.com.
Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
Press@amwell.com
Investors:
Sue Dooley
sue.dooley@amwell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.